TrialDiabetes care2009
Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes.
Claus M Larsen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
193 papers cite itlatest 60 shown
this paperpooled ittrialcites it